Large Genomic Profiling Study Sees Mutation-Rich Tumors From Many Cancer Types

NEW YORK (GenomeWeb) – Profiling mutations in a few hundred genes appears to be a promising method for identifying mutation-rich tumors that may respond to drugs that target the immune checkpoint pathway, according to a new research study led by Foundation Medicine.

Get the full story This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
.

Be the first to comment

Leave a Reply

Your email address will not be published.


*